We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

149 hedge funds and large institutions have $1.12B invested in Impax Laboratories, Inc. in 2013 Q2 according to their latest regulatory filings, with 149 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $7.28M

Holders
149
Holders Change
+149
Holders Change %
–
% of All Funds
4.86%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
149
Increased
–
Reduced
–
Closed
–
Calls
$3.82M
Puts
$7.28M
Net Calls
-$3.46M
Net Calls Change
-$3.46M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$98.3M +$87.5M +4,929,674 New
BFA
2
BlackRock Fund Advisors
California
$82.8M +$73.7M +4,152,160 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$78.8M +$70.1M +3,951,140 New
O
4
OrbiMed
New York
$65M +$57.9M +3,260,600 New
RIM
5
RS Investment Management
California
$50.1M +$44.6M +2,511,525 New
State Street
6
State Street
Massachusetts
$45.6M +$40.5M +2,283,591 New
Ameriprise
7
Ameriprise
Minnesota
$45.4M +$40.4M +2,274,982 New
UBS AM
8
UBS AM
Illinois
$43.1M +$38.3M +2,159,059 New
BIT
9
BlackRock Institutional Trust
California
$37.3M +$33.2M +1,868,975 New
Citadel Advisors
10
Citadel Advisors
Florida
$30.4M +$27M +1,522,135 New
AC
11
Apex Capital
California
$29.6M +$26.4M +1,485,000 New
BC
12
Broadfin Capital
New York
$27.9M +$24.8M +1,398,543 New
AC
13
Ascend Capital
California
$26M +$23.2M +1,304,476 New
Millennium Management
14
Millennium Management
New York
$22.8M +$20.3M +1,141,826 New
Northern Trust
15
Northern Trust
Illinois
$21.1M +$18.8M +1,057,409 New
RG
16
Redmile Group
California
$19.2M +$17.1M +961,100 New
Invesco
17
Invesco
Georgia
$19.1M +$17M +958,720 New
Renaissance Technologies
18
Renaissance Technologies
New York
$18.9M +$16.8M +946,300 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$18.1M +$16.1M +908,641 New
Jennison Associates
20
Jennison Associates
New York
$17.2M +$15.3M +859,985 New
HM
21
HealthCor Management
New York
$16.5M +$14.7M +826,300 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$14.3M +$12.7M +716,902 New
CM
23
CS McKee
Pennsylvania
$14.2M +$12.7M +713,410 New
JHIU
24
Janus Henderson Investors US
Colorado
$13.8M +$12.3M +691,582 New
Franklin Resources
25
Franklin Resources
California
$13.4M +$11.9M +669,731 New
1
2 3 4 5

IPXL Hedge Fund Activity: Q2 2013 in Review

149 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q2 2013, worth a combined $1.12B.

Buyers outnumbered sellers: 149 funds opened new IPXL positions and 0 closed out — a net gain of 149 holders — while 0 added to existing stakes and 0 trimmed.

  • 149 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.12B of Impax Laboratories, Inc. stock for Q2 2013.
  • 149 funds opened new Impax Laboratories, Inc. positions in Q2 2013 and 0 closed out, a net change of +149 holders.

Based on aggregated 13F filings for Q2 2013.